Labcorp Holdings Inc.
LH
$253.03
-$1.04-0.41%
| Weiss Ratings | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | C+ | |||
| Rating Factors | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.44 | |||
| Price History | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.67% | |||
| 30-Day Total Return | 3.87% | |||
| 60-Day Total Return | 9.11% | |||
| 90-Day Total Return | 10.62% | |||
| Year to Date Total Return | 11.21% | |||
| 1-Year Total Return | 17.36% | |||
| 2-Year Total Return | 30.58% | |||
| 3-Year Total Return | 14.64% | |||
| 5-Year Total Return | 73.67% | |||
| 52-Week High % Change | -1.75% | |||
| 52-Week Low % Change | 32.35% | |||
| Price | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $258.59 | |||
| 52-Week Low Price | $191.97 | |||
| 52-Week Low Price (Date) | May 31, 2024 | |||
| 52-Week High Price (Date) | Jan 30, 2025 | |||
| Valuation | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 21.27B | |||
| Enterprise Value | 27.11B | |||
| Price/Earnings (TTM) | 28.79 | |||
| Earnings Per Share (TTM) | 8.83 | |||
| Earnings Per Share Growth | 89.56% | |||
| Price/Earnings To Growth | 0.32 | |||
| Price/Sales (TTM) | 1.64 | |||
| Price/Book (Q) | 2.63 | |||
| Enterprise Value/Revenue (TTM) | 2.08 | |||
| Price | $253.03 | |||
| Enterprise Value/EBITDA (TTM) | 15.99 | |||
| Enterprise Value/EBIT | 23.95 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 84.20M | |||
| Dividend Yield | 1.13% | |||
| Div. Per Share (Most Recent) | $0.72 | |||
| Dividend Per Share (TTM) | $2.88 | |||
| Payout Ratio (TTM) | 32.59% | |||
| Dividend Per Share (Most Recent) | $0.72 | |||
| Company Info | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 336 229 1127 | |||
| Address | 358 South Main Street Burlington, NC 27215 | |||
| Website | www.labcorp.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 8.70% | |||
| Profit Margin | 5.73% | |||
| Management Effectiveness | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.03% | |||
| Return on Equity | 9.36% | |||
| Income Statement | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 13.01B | |||
| Total Revenue (TTM) | 13.01B | |||
| Revenue Per Share | $154.50 | |||
| Gross Profit (TTM) | 3.62B | |||
| EBITDA (TTM) | 1.70B | |||
| EBIT (TTM) | 1.13B | |||
| Net Income (TTM) | 746.00M | |||
| Net Income Avl. to Common (TTM) | 746.00M | |||
| Total Revenue Growth (Q YOY) | 9.76% | |||
| Earnings Growth (Q YOY) | 186.09% | |||
| EPS Diluted (TTM) | 8.83 | |||
| EPS Diluted Growth (Q YOY) | 186.57% | |||
| Balance Sheet | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.52B | |||
| Cash Per Share (Q) | $18.04 | |||
| Total Current Assets (Q) | 4.81B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 8.07B | |||
| Current Ratio (Q) | 1.443 | |||
| Book Value Per Share (Q) | $96.55 | |||
| Total Assets (Q) | 18.38B | |||
| Total Current Liabilities (Q) | 3.33B | |||
| Total Debt (Q) | 7.35B | |||
| Total Liabilities (Q) | 10.31B | |||
| Total Common Equity (Q) | 8.05B | |||
| Cash Flow | LH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.37B | |||
| Cash from Financing (TTM) | 779.90M | |||
| Net Change in Cash (TTM) | 981.90M | |||
| Levered Free Cash Flow (TTM) | 824.24M | |||
| Cash from Operations (TTM) | 1.59B | |||
